Literature DB >> 21346070

The genetics of bone loss: challenges and prospects.

Braxton D Mitchell1, Laura M Yerges-Armstrong.   

Abstract

CONTEXT: A strong genetic influence on bone mineral density has been long established, and modern genotyping technologies have generated a flurry of new discoveries about the genetic determinants of bone mineral density (BMD) measured at a single time point. However, much less is known about the genetics of age-related bone loss. Identifying bone loss-related genes may provide new routes for therapeutic intervention and osteoporosis prevention. EVIDENCE ACQUISITION: A review of published peer-reviewed literature on the genetics of bone loss was performed. Relevant studies were summarized, most of which were drawn from the period 1990-2010. EVIDENCE SYNTHESIS: Although bone loss is a challenging phenotype, available evidence supports a substantial genetic contribution. Some of the genes identified from recent genome-wide association studies of cross-sectional BMD are attractive candidate genes for bone loss, most notably genes in the nuclear factor κB and estrogen endocrine pathways. New insights into the biology of skeletal development and regulation of bone turnover have inspired new hypotheses about genetic regulation of bone loss and may provide new directions for identifying genes associated with bone loss.
CONCLUSIONS: Although recent genome-wide association and candidate gene studies have begun to identify genes that influence BMD, efforts to identify susceptibility genes specific for bone loss have proceeded more slowly. Nevertheless, clues are beginning to emerge on where to look, and as population studies accumulate, there is hope that important bone loss susceptibility genes will soon be identified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346070      PMCID: PMC3085199          DOI: 10.1210/jc.2010-2865

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  103 in total

1.  Apolipoprotein E gene polymorphism and bone loss: estrogen status modifies the influence of apolipoprotein E on bone loss.

Authors:  L M Salamone; J A Cauley; J Zmuda; A Pasagian-Macaulay; R S Epstein; R E Ferrell; D M Black; L H Kuller
Journal:  J Bone Miner Res       Date:  2000-02       Impact factor: 6.741

2.  Associations of the collagen type Ialpha1 Sp1 polymorphism with five-year rates of bone loss in older adults.

Authors:  S S Harris; M S Patel; D E Cole; B Dawson-Hughes
Journal:  Calcif Tissue Int       Date:  2000-04       Impact factor: 4.333

3.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

Review 4.  Androgens and osteoporosis.

Authors:  Peter R Ebeling
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-06       Impact factor: 3.243

5.  Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men.

Authors:  Howard A Fink; Susan K Ewing; Kristine E Ensrud; Elizabeth Barrett-Connor; Brent C Taylor; Jane A Cauley; Eric S Orwoll
Journal:  J Clin Endocrinol Metab       Date:  2006-07-18       Impact factor: 5.958

6.  Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women.

Authors:  Susan P Moffett; Joseph M Zmuda; Jane A Cauley; Katie L Stone; Michael C Nevitt; Kristine E Ensrud; Teresa A Hillier; Marc C Hochberg; Geoff Joslyn; Phillip Morin; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2004-07-12       Impact factor: 6.741

Review 7.  Medication-induced osteoporosis.

Authors:  Meng-Yi Weng; Nancy E Lane
Journal:  Curr Osteoporos Rep       Date:  2007-12       Impact factor: 5.096

8.  Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study.

Authors:  G Jones; T Nguyen; P Sambrook; P J Kelly; J A Eisman
Journal:  BMJ       Date:  1994-09-17

9.  Powerful bivariate genome-wide association analyses suggest the SOX6 gene influencing both obesity and osteoporosis phenotypes in males.

Authors:  Yao-Zhong Liu; Yu-Fang Pei; Jian-Feng Liu; Fang Yang; Yan Guo; Lei Zhang; Xiao-Gang Liu; Han Yan; Liang Wang; Yin-Ping Zhang; Shawn Levy; Robert R Recker; Hong-Wen Deng
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

10.  Genome-wide association studies identify loci associated with age at menarche and age at natural menopause.

Authors:  Chunyan He; Peter Kraft; Constance Chen; Julie E Buring; Guillaume Paré; Susan E Hankinson; Stephen J Chanock; Paul M Ridker; David J Hunter; Daniel I Chasman
Journal:  Nat Genet       Date:  2009-05-17       Impact factor: 38.330

View more
  13 in total

1.  Replication study of three functional polymorphisms associated with bone mineral density in a cohort of Spanish women.

Authors:  Layla Panach; Damián Mifsut; Juan J Tarín; Antonio Cano; Miguel Ángel García-Pérez
Journal:  J Bone Miner Metab       Date:  2013-12-14       Impact factor: 2.626

2.  Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).

Authors:  S C Kaste; A Qi; K Smith; H Surprise; E Lovorn; J Boyett; R J Ferry; M V Relling; S A Shurtleff; C H Pui; L Carbone; M M Hudson; K K Ness
Journal:  Pediatr Blood Cancer       Date:  2014-01-07       Impact factor: 3.167

3.  Greater yogurt consumption is associated with increased bone mineral density and physical function in older adults.

Authors:  E Laird; A M Molloy; H McNulty; M Ward; K McCarroll; L Hoey; C F Hughes; C Cunningham; J J Strain; M C Casey
Journal:  Osteoporos Int       Date:  2017-05-01       Impact factor: 4.507

4.  The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors.

Authors:  Peggy Benisch; Tatjana Schilling; Ludger Klein-Hitpass; Sönke P Frey; Lothar Seefried; Nadja Raaijmakers; Melanie Krug; Martina Regensburger; Sabine Zeck; Thorsten Schinke; Michael Amling; Regina Ebert; Franz Jakob
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

5.  Relationship between CATSPERB, NR5A2 gene polymorphisms and Peak Bone Mineral Density in College Students in China.

Authors:  Yuan Zhao; Wenya Liu; Ma Hua; Raoni Shi; Haitao Wang; Wen Yang
Journal:  Iran J Public Health       Date:  2014-08       Impact factor: 1.429

Review 6.  Bone turnover markers: Emerging tool in the management of osteoporosis.

Authors:  Sahana Shetty; Nitin Kapoor; Joseph Dian Bondu; Nihal Thomas; Thomas Vizhalil Paul
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

7.  Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women.

Authors:  Merih Ozgen; Didem Turgut Cosan; Fulya Doganer; Ahu Soyocak; Onur Armagan; Hasan Veysi Gunes; Irfan Degirmenci; Gulsah Ogutler Ozkara; Fezan Sahin Mutlu
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

Review 8.  Genome-wide approaches for identifying genetic risk factors for osteoporosis.

Authors:  Shuyan Wu; Yongjun Liu; Lei Zhang; Yingying Han; Yong Lin; Hong-Wen Deng
Journal:  Genome Med       Date:  2013-05-29       Impact factor: 11.117

Review 9.  Clinical impact of recent genetic discoveries in osteoporosis.

Authors:  Braxton D Mitchell; Elizabeth A Streeten
Journal:  Appl Clin Genet       Date:  2013-10-04

10.  Network Analysis Implicates Alpha-Synuclein (Snca) in the Regulation of Ovariectomy-Induced Bone Loss.

Authors:  Gina Calabrese; Larry D Mesner; Patricia L Foley; Clifford J Rosen; Charles R Farber
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.